6braham WT,Kowes BD,Fergusan DA,et al.Systemic hemodynanmic,neurohonnenal,and renal excretory effects of a steady state infusion of human brain natriuretic peptide in patient with decompensated chronic heart failure[J].J Card Fail,1998,4(1):37 - 44
7Kawakami R,Saito Y,Kishimoto I,et al.Over expression of brain natriuretic peptide facilitates neutrophil infiltration and cardiac matrix metalloproteinase-9 expression after acute myocardial infarctien[J].Circulation,2004,,110(21):3306-3312
8Keating GM,Goa KL.Nesiritide:a review of its use in acute decompensated heart failure[J].Drugs,2003,63(1):47-70
9Strain WD.The use of recombinant human B-type natriutetic peptide(nesiritide) in the management,of acute decompensated heat failunre[J].Int J Clin Pract,2004,58(11):1081-1087
10Gordon W Moe,Jonathan Howlett,James L.Response to letter regarding articly,“N-terminal Pro-B-type natriuretic peptide testing improves the mangement of patients with suspected acute heart failure:primary results of the canadian prospective randomized muhicenter IMPROVE-CHF study”[J].Cirulation,2008,117(1):6
3Khurana S,Raufman JP, Pallone TL. Bile acids regulate cardiovascu- larfunction [ J ].Clin Trans Sci, 2011,4( 3 ): 210-218.
4Tycinska AM,Sawicki R,Mroczko B,et al. Admission B-type natruretic peptide level predicts long term survival in low risk ST-elevation my- ocardial infarction patien [ J ].Cardiol Pol, 2011,69 (10) : 1008-1014.
5Ploug KB,Baun M,Hay-Schmidt A,et al. Presence and vascular phar- macology of KATP channel subtypes in rat central and peripheral tis- sues[J ].Eur.l Pharmacol,2010.637( 1 ):109-117.
